Literature DB >> 26577855

An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population.

Dali Feng1,2, Hui Xu1, Xin Li2, Yuehua Wei1, Huangang Jiang1, Hong Xu2, Aihua Luo2, Fuxiang Zhou3,4,5.   

Abstract

The aim was to analyze quantitative (mitochondrial DNA (mtDNA) content) and qualitative (G10398A polymorphism) mtDNA alterations as well as human papillomavirus (HPV) infection in cervical cancer prognosis. One hundred and twenty-two cases of formalin-fixed paraffin-embedded cervical carcinoma specimens were collected from the Yichang Tumor Hospital and Zhongnan Hospital of Wuhan University in the recent 10 years together with medical records. A quantitative real-time PCR (RT-PCR) was used to determine the copy number of the mitochondrial DNA and HPV expression levels. G10398A polymorphism was determined by PCR-RFLP assay. The overall survival of patients with higher mtDNA content was significantly reduced compared with lower mtDNA content patients (P = 0.029). But there was no difference of prognosis between the mtDNA 10398 A allele and G allele. However, the Kaplan-Meier survival curve illustrated a significantly reduced overall survival in the patients with 10398A plus high mtDNA copy number compared with the other groups (P < 0.05). Although no association between HPV expression level and cervical cancer prognosis was observed, 10398A got increased mtDNA content compared with 10398G (P < 0.05) and 10398G displayed an increased HPV-positive rate compared with 10398A. Furthermore, HPV-18 and mtDNA content were positively related in the younger subgroup (≤45 years) (correlation coefficient = 0.456, P = 0.022). This study indicated that mtDNA content and HPV infection status are associated with cervical cancer prognosis. High mitochondrial DNA content plus 10398 A may be a marker of poor prognosis in cervical cancer. And mtDNA variation may potentially influence the predisposition to HPV infection and cervical carcinogenesis.

Entities:  

Keywords:  10398 site; Cervical cancer; HPV; Mitochondrial DNA content; Prognosis

Mesh:

Substances:

Year:  2015        PMID: 26577855     DOI: 10.1007/s13277-015-4429-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  1 in total

Review 1.  Mitochondria, energetics, epigenetics, and cellular responses to stress.

Authors:  Daniel T Shaughnessy; Kimberly McAllister; Leroy Worth; Astrid C Haugen; Joel N Meyer; Frederick E Domann; Bennett Van Houten; Raul Mostoslavsky; Scott J Bultman; Andrea A Baccarelli; Thomas J Begley; Robert W Sobol; Matthew D Hirschey; Trey Ideker; Janine H Santos; William C Copeland; Raymond R Tice; David M Balshaw; Frederick L Tyson
Journal:  Environ Health Perspect       Date:  2014-08-15       Impact factor: 9.031

  1 in total
  9 in total

1.  Sequence variations of mitochondrial DNA D-loop region in patients with acute myeloid leukemia.

Authors:  Juan Zhou; Haimei Gou; Yuanxin Ye; Yi Zhou; Xiaojun Lu; Binwu Ying
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

2.  Elevated Mitochondrial DNA Copy Number in Peripheral Blood and Tissue Predict the Opposite Outcome of Cancer: A Meta-Analysis.

Authors:  Nan Chen; Shu Wen; Xiaoru Sun; Qian Fang; Lin Huang; Shuai Liu; Wanling Li; Meng Qiu
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

Review 3.  Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.

Authors:  Anton M F Kalsbeek; Eva K F Chan; Niall M Corcoran; Christopher M Hovens; Vanessa M Hayes
Journal:  Oncotarget       Date:  2017-08-04

4.  Altered mitochondrial DNA copy number contributes to human cancer risk: evidence from an updated meta-analysis.

Authors:  Liwen Hu; Xinyue Yao; Yi Shen
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

5.  Mitochondrial DNA copy number in cervical exfoliated cells and risk of cervical cancer among HPV-positive women.

Authors:  Wei Sun; Xueyun Qin; Jing Zhou; Mingjing Xu; Zhangyan Lyu; Xin Li; Kai Zhang; Min Dai; Ni Li; Dong Hang
Journal:  BMC Womens Health       Date:  2020-07-02       Impact factor: 2.809

Review 6.  Roles of mitochondrial DNA in dynamics of the immune response to COVID-19.

Authors:  Ata Mahmoodpoor; Sarvin Sanaie; Zoherh Ostadi; Maqsoud Eskandari; Nazila Behrouzi; Roqayyeh Asghari; Ahmad Zahirnia; Nasim Sohrabifar; Somayeh Kazeminasab
Journal:  Gene       Date:  2022-06-18       Impact factor: 3.913

Review 7.  HPV-Negative Cervical Cancer: A Narrative Review.

Authors:  Francesca Arezzo; Gennaro Cormio; Vera Loizzi; Gerardo Cazzato; Viviana Cataldo; Claudio Lombardi; Giuseppe Ingravallo; Leonardo Resta; Ettore Cicinelli
Journal:  Diagnostics (Basel)       Date:  2021-05-26

8.  Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.

Authors:  Ping Li; Yue Tan; Li-Xia Zhu; Li-Na Zhou; Ping Zeng; Qin Liu; Min-Bin Chen; Ye Tian
Journal:  Oncotarget       Date:  2017-06-16

Review 9.  Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers.

Authors:  Hiroshi Yoshida; Kouya Shiraishi; Tomoyasu Kato
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.